Home › Funds › Lynx1 Capital Management LP › HOWL
Lynx1 Capital Management LP position in HOWL
WEREWOLF THERAPEUTICS INC · Health Care
Lynx1 Capital Management LP reported holding 657,786 shares of HOWL (WEREWOLF THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$237K, representing 0.03% of its reported portfolio and ranking #21 among its reported holdings. Lynx1 Capital Management LP has disclosed HOWL holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Lynx1 Capital Management LP's HOWL position evolved
Lynx1 Capital Management LP first disclosed a stake in HOWL in Q4 2025 at 655,926 shares (US$416K). The position peaked in Q1 2026 at 657,786 shares, worth US$548K. Across 3 filings, Lynx1 Capital Management LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 657,786 shares valued at US$237K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 655.93K | $415.53K | New |
| Q1 2026 | 657.79K | $547.67K | Hold |
| Q2 2026 | 657.79K | $236.74K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HOWL and 13F data
HOWL (WEREWOLF THERAPEUTICS INC) is a Health Care company. 14 other funds we track also report a position in HOWL — the largest reported positions include DC Funds, LP (US$212.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on Lynx1 Capital Management LP
FAQ
How long has Lynx1 Capital Management LP held HOWL?
Lynx1 Capital Management LP has disclosed HOWL holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Lynx1 Capital Management LP's current position in HOWL?
As of Q2 2026, Lynx1 Capital Management LP holds 657.79K shares of HOWL (WEREWOLF THERAPEUTICS INC), valued at $236.74K, representing 0.03% of its reported portfolio and ranking #21.
Has Lynx1 Capital Management LP been buying or selling HOWL?
In the latest 13F filing (Q2 2026), Lynx1 Capital Management LP held unchanged its position in HOWL. The position peaked in Q1 2026 at 657.79K shares.
Which other funds hold HOWL?
Other major institutional holders of HOWL include DC Funds, LP, among 14 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.